Skip to main content
logo
Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
1.870
-0.120 (-6.03%)
At close: Sep 12, 2025, 4:00 PM EDT
1.898
+0.028 (1.51%)
After-hours: Sep 12, 2025, 7:37 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Immuno-inflammatory Disorders Therapies
41.10M
Log In
Log In
Immuno-inflammatory Disorders Therapies Growth
13.89%
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
United States
41.10M
Log In
Log In
United States Growth
13.89%
Log In
Log In